PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
55 hedge funds and large institutions have $113M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 19 reducing their positions, and 19 closing their positions.
Holders
55
Holders Change
-6
Holders Change %
-9.84%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
12
Reduced
19
Closed
19
Calls
$119K
Puts
$45K
Net Calls
+$74K
Net Calls Change
+$53K